- Home
- DTSS vs IRIX Comparison
DTSS vs IRIX Comparison
Compare DTSS & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSS
- IRIX
- Stock Information
- Founded
- DTSS 2014
- IRIX 1989
- Country
- DTSS China
- IRIX United States
- Employees
- DTSS N/A
- IRIX N/A
- Industry
- DTSS Computer Software: Prepackaged Software
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DTSS Technology
- IRIX Health Care
- Exchange
- DTSS Nasdaq
- IRIX Nasdaq
- Market Cap
- DTSS 17.6M
- IRIX 20.2M
- IPO Year
- DTSS N/A
- IRIX 1996
- Fundamental
- Price
- DTSS $1.95
- IRIX $1.01
- Analyst Decision
- DTSS
- IRIX
- Analyst Count
- DTSS 0
- IRIX 0
- Target Price
- DTSS N/A
- IRIX N/A
- AVG Volume (30 Days)
- DTSS 39.1K
- IRIX 60.7K
- Earning Date
- DTSS 11-12-2025
- IRIX 11-11-2025
- Dividend Yield
- DTSS N/A
- IRIX N/A
- EPS Growth
- DTSS N/A
- IRIX N/A
- EPS
- DTSS N/A
- IRIX N/A
- Revenue
- DTSS $71,616,820.00
- IRIX $49,744,000.00
- Revenue This Year
- DTSS N/A
- IRIX $9.61
- Revenue Next Year
- DTSS N/A
- IRIX N/A
- P/E Ratio
- DTSS N/A
- IRIX N/A
- Revenue Growth
- DTSS 198.70
- IRIX 0.09
- 52 Week Low
- DTSS $1.63
- IRIX $0.78
- 52 Week High
- DTSS $3.10
- IRIX $1.95
- Technical
- Relative Strength Index (RSI)
- DTSS 46.29
- IRIX 36.05
- Support Level
- DTSS $1.88
- IRIX $1.05
- Resistance Level
- DTSS $1.98
- IRIX $1.09
- Average True Range (ATR)
- DTSS 0.08
- IRIX 0.05
- MACD
- DTSS -0.00
- IRIX 0.00
- Stochastic Oscillator
- DTSS 57.14
- IRIX 3.85
About DTSS Datasea Inc.
Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.